Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Leadership
Board of Directors
Scientific Advisors (DMD)
Our Science
Deramiocel (Biologic Medicine)
Exosomes Technology
Publications
Strategic Partnerships
Pipeline
Pipeline
Duchenne Muscular Dystrophy Overview
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact
Annual Reports
Investors
Investors
Overview
News & Events
Overview
Press Releases
In the News
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Leadership
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Latest Proxy Statement and Annual Report
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
10-K
10-K/A
10KSB
10KSB/A
ARS
NT 10-K
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Date
Form
Description
PDF
XBRL
Pages
03/31/03
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
3
04/15/02
10KSB
Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]
21
03/28/02
NT 10-K
Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
3
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Select a page:
Page 1
Page 2
Page 3
Page 4
Email Alerts
Company Profile
Contacts
RSS News Feed